Several molecules of the Fibroblast growth factor family have been implicated in the development of the vertebrate brain, but the effectors of these molecules remain largely unknown. Here we study Erm and Pea3, two ETS domain transcription factors, and show that their expression correlates closely with the domains of fgf8 and fgf3 expression. In situ hybridization analysis in wild-type and acerebellar (ace) mutant embryos defective for fgf8 demonstrates a requirement of Fgf8 for normal expression levels of erm and pea3 transcripts in and close to various domains of Fgf8 action, including the prospective midbrain±hindbrain region, the somites, the neural crest, the forebrain, and developing eyes. Morpholino-oligomer-assisted gene knock-down experiments targeted against fgf8 and fgf3 suggest that Fgf3 and Fgf8 are co-regulators of these genes in the early forebrain anlage. Furthermore, inhibition of Fgf signaling by overexpression of sprouty4 or application of the Fgf inhibitor SU5402 leads to a loss of all erm and pea3 expression domains. Conversely, ectopically provided fgf3 mRNA or implanted beads coated with Fgf8 elicit ectopic transcription of erm and pea3. Both activation and loss of transcripts can be observed within short time frames. We conclude that both the transcriptional onset and maintenance of these factors are tightly coupled to Fgf signaling and propose that erm and pea3 transcription is a direct readout of cells to Fgf levels. Given the knowledge that has accumulated on the posttranslational control of ETS domain factors and their combinatorial interactions with other transcription factors, we suggest that the close coupling of erm and pea3 transcription to Fgf signaling might serve to integrate Fgf signaling with other signals to establish re®ned patterns in embryonic development. q
Introduction
Molecules of the Fibroblast growth factor (Fgf) family play crucial roles in patterning the vertebrate embryo Ornitz and Itoh, 2001) . During regionalization of the neural plate Fgf8, in particular, acts as a potent organizing molecule, affecting cellular events as diverse as cellular identity, cell survival, proliferation, and axonal navigation (Crossley et al., 1996; Lee et al., 1997; Reifers et al., 1998 Reifers et al., , 2000b Meyers et al., 1998; Martinez et al., 1999; Picker et al., 1999; Shanmugalingam et al., 2000; Xu et al., 2000) . To understand how these different responses are elicited, and how they lead to proper organization of the midbrain±hindbrain (MH) region, it is important to gain insight into the events downstream of Fgf receptor activity in the brain anlage of vertebrate embryos.
Pattern formation in the MH region occurs in several discrete steps. Initially, the interface between the expression domains of two homeodomain transcription factors of the Gbx ond Otx class positions the MH organizing center in the anterior neural plate already during gastrulation stages. Subsequently, several signaling pathways employing wnt1, pax2.1, and fgf8 are initiated in discrete expression domains around the position of the incipient MH organizer. While expression of these genes is initiated independently of each other, their interplay is essential to produce and/or to maintain the MH organizer. Once generated, the organizer controls cell-type speci®city in the surrounding neural plate through secreting patterning molecules like Fgf8, Fgf17, and Wnt1 (reviewed in Joyner et al., 2000; Rhinn and Brand, 2001; Wurst and Bally-Cuif, 2001; Nakamura, 2001) . It is currently not understood how the various signaling factors interact to specify distinct gene expression domains in the MH domain, and how the various signaling events are integrated and relayed. In this paper, we study the relationship between Fgf signaling and the Ets family transcription factors Erm and Pea3 as putative downstream targets. ETS domain proteins are a family of transcription factors that have been implicated in a variety of transcriptional regulatory events controlling normal and abnormal cell behavior, including proliferation, differentiation, and migration (reviewed in Wasylyk et al., 1998) . These proteins share an 85 amino acid winged-helix±loop±helix domain (the Erythroblastoma Twenty-Six (ETS) domain) with which they bind to DNA as monomers. Characteristically, ETS domain factors are involved in transcriptional control mechanisms that specify diverse sets of gene expressions as they are needed for tissue patterning and lineage commitment, e.g. the commitment of lymphoid cells to the T cell lineage (Anderson et al., 1999) . A recurring theme in ETS domain protein function is the ability of these factors to form heterocomplexes with other types of transcription factors. Examples include the interaction of TCF-like ETS proteins as Elk-1/SAP-1 with serum response factor on the c-fos promoter (Dalton and Treisman, 1992) , the association of Ets-1 with the bZIP protein MafB to regulate transcription of the transferrin receptor gene (Sieweke et al., 1996) , the interaction of Ets-1 with the POU Homeodomain of Pit-1 (Bradford et al., 2000 and references therein) and the recruitment of Ets-1, Net, or Elk-1 to the mb-1 promoter by the paired homeodomain protein Pax5 (Fitzsimmons et al., 1996) .
An additional feature of ETS domain proteins is their posttranslational modi®cation by cell signaling pathways. Most prominently, the Ras±Raf±mitogen activated protein kinase (MAPK) pathway has been demonstrated to target family members of the ETS, YAN, ELF, ERF, TCF, and PEA3 classes of ETS domain proteins (see Wasylyk et al., 1998 and references therein). In Drosophila, as an example, speci®cation of R7 photoreceptor development requires activation of the Ras-MAP kinase pathways by the SEVEN-LESS receptor tyrosine kinase. Two antagonistic ETS proteins serve as targets of MAP kinases in this system: PointedP2, which becomes activated, and YAN, which loses its R7 cell fate inhibitory function upon phosphorylation (O'Neill et al., 1994) . Similarly, this system seems to have been employed in ventral ectoderm patterning (reviewed in Schweitzer and Shilo, 1997) .
In this study, we focus on the transcriptional control of two vertebrate ETS domain factors, erm (ETS related molecule, Monte et al., 1994) and pea3 (Polyoma enhancer activator 3, Xin et al., 1992; Higashino et al., 1993) in early zebra®sh development. Zebra®sh Erm and Pea3 (Brown et al., 1998; constitute the only known zebra®sh members of the Pea3 subgroup of ETS domain factors which in addition includes ER81 (Janknecht, 1996) . ER81 has been proposed to act downstream of eFgf signaling in the gastrulating Xenopus laevis embryo and to interfere with activin signaling when overexpressed in animal caps (Chen et al., 1999) . Pea3 and ER81 have been characterized in chicken and mice as factors involved in the de®nition of motor neuron pools and corresponding sensory afferents (Lin et al., 1998, reviewed in Ghosh and Kolodkin, 1998) . Loss of function studies with ER81 support that this subdivision is functionally relevant for the establishment of sensory-motor circuits at the limb level (Arber et al., 2000) . Furthermore, in vitro studies have provided evidence that Pea3 can be activated through phosphorylation by MAP kinases of both the extracellular signal-related kinase (ERK) and the c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) (O'Hagan et al., 1996) , and that Erm is targeted by MAP kinase and protein kinase A signaling , thus supporting their roles as nuclear effectors of extracellular signaling.
A brief report on the distribution of erm and pea3 transcripts in zebra®sh has appeared previously , but both the establishment and maintenance of their expression pattern as well as the possible function of these genes have remained unclear. Here we demonstrate that erm and pea3 are expressed in close proximity to centers of Fgf signaling throughout embryogenesis and that they are highly susceptible to interference with intracellular Fgf signaling. Speci®cally, lack of fgf8 gene function in the acerebellar (ace) mutant or morpholinoantisense`knock-down' experiments affecting fgf8 and fgf3 translation suggests that Fgf8 and Fgf3 are two regulators of the transcription of erm and pea3 in speci®c expression domains, including the MH region and the forebrain. Finally, RNA misexpression and bead implantation experiments show that both Fgf3 and Fgf8 are able to ectopically activate erm and pea3 transcription with fast kinetics. We conclude that erm and pea3 transcription is tightly linked to Fgf signaling and may provide a direct intracellular readout for Fgfs.
Results

pea3 and erm are co-expressed with fgfs during early embryonic development
In order to compare the transcriptional regulation of erm and pea3 to sites of Fgf signaling, we performed wholemount in situ hybridizations (ISHs) with antisense probes of full-length erm and pea3 as well as fgf8 and fgf3, two fgf genes that are expressed during early zebra®sh development (Kiefer et al., 1996; Fu Èrthauer et al., 1997; Reifers et al., 1998 and this paper) . Analysis of erm and pea3 expression reveals a strong correlation with the expression domains of both fgf8 and fgf3, except for early cleavage stages, when erm and pea3 RNAs are provided maternally and show global distribution throughout the embryo ( Fig. 1 and data not shown). Transcripts become progressively restricted to the margin of the pregastrula, where fgf8 and fgf3 are also expressed. With the beginning of gastrulation, expression of fgf8, erm, and pea3 diminishes ventrally, but stays strong dorsally, at the site of the embryonic shield (Fig. 1A) . At 70% of epiboly, fgf3 expression can be detected in the ante-rior region of the prospective neural plate, while fgf8 starts to be expressed in the prospective midbrain/anterior hindbrain region (Reifers et al., 1998) . Anterior fgf3 expression recedes to a telencephalic domain until gastrula stage. At 80±90% of epiboly, erm and pea3 transcripts accumulate at similar levels as fgf3 and fgf8 in the prospective fore-and MH, respectively, becoming re®ned until tailbud stage to a horseshoe-shaped domain around the prospective forebrain, to the territory covering posterior midbrain and anterior hindbrain, the lateral ectoderm at the MH level, the trunk as well as the tailbud (Fig. 1B) . At the onset of somitogenesis, fgf8 becomes similarly expressed in the prospective forebrain (Reifers et al., 1998) . Transcripts of erm and pea3 are present in the prospective telencephalon during segmentation stages, with a slightly stronger expression at the basal side (Fig. 1C,D) . In addition, erm and pea3 expression persists in the MH boundary (MHB), the hindbrain and the adjacent ectoderm as well as in the eye anlage and in the somites, which are all regions of fgf8 localization ( Fig. 1 ; Reifers et al., 1998 and data not shown). Expression of fgf3 is also found in the tailbud, the MHB, in part of the hindbrain, and the presumptive otic placode (Fig. 1C) .
Characteristically, the expression domains of erm and pea3 are broader and less con®ned than the expression domains of either fgf8 or fgf3. This is for example evident during gastrulation stages, when both erm and pea3 expres- (.) , the margin of the ventrolateral expression domains during gastrulation (arrowheads), the expression in the forebrain (asterisks), at the level of the posterior midbrain/anterior hindbrain (brackets) and the somites (arrows). Prominent staining for erm and pea3 at the hindbrain level in panels (C) and (C H ) stems mostly from placodal expression and is paralleled by expression of both fgf8 and fgf3.
sion extend further ventrolaterally than fgf8 (Fig. 1B) . Similarly, the forebrain expression domains of fgf3 and fgf8 are narrow and precise, while the expression of erm and pea3 are more extensive (Fig. 1B±D) . In addition to spatial distribution of transcripts, expression dynamics of these factors seems to be temporally pre®gured by expression changes of fgf8 or fgf3. This can be observed in the re®nement of expression patterns in the anterior neural plate during late gastrulation: erm and pea3 transcripts are progressively accumulating around the emanating expression domains of fgf3 and fgf8 in the prospective forebrain and MH regions, respectively, while they are at the same time lost from interspatial domains (Fig. 1B and data not shown) .
Finally, when erm and pea3 expression are compared to each other, erm transcripts appear spatially less restricted than pea3 transcripts. Thus, during gastrulation, erm expands further ventrolaterally than pea3 (arrowheads in Fig. 1B ). At tailbud stage, different expression domains of pea3 within the prospective MH region and the adjacent tissues can be clearly distinguished, while erm expression Fig. 2 . Embryos lacking fgf8 gene function display a loss in speci®c erm and pea3 expression domains. Whole-mount ISHs were performed with digoxigeninlabeled antisense probes of erm (panels C and G) or pea3 (all other panels), both detected in blue, in combination with a¯uorescein-labeled antisense probe of pax2.1 (panels A±E H ), detected in red. Expression is compared between wild-type (panels A±I) and homozygous ace embryos (panels A 
(H, H
H ) pea3 fails to be reexpressed at the MHB (asterisk) at later stages (I, I H ). After early segmentation stages, MHB expression (asterisk) is progressively affected in noi mutant embryos, correlating with the loss of fgf8 from this domain.
is found in a more uniform domain that seems to contain all expression domains of pea3 ( Fig. 2B ,C; further discussed below). Similar observations can be made at other stages and expression sites, e.g. at the 12 somite stage, where corresponding correlations are found in the forebrain domain, the MHB, the somites, and the tailbud domain (Fig. 1C) , suggesting that erm and pea3 follow different kinetics or respond to different thresholds of the same signal.
Normal expression levels of erm and pea3 depend on fgf8 function in many expression domains
Spatial co-expression has been suggested to be a characteristic feature of functionally linked genes (Niehrs and Pollet, 1999) . The observed co-expression of erm, pea3, fgf8, and fgf3 prompted us to study the possibility of a functional link between the transcription of these ETS factors and Fgf signaling under conditions of altered Fgf signaling in the embryo. First, we investigated the expression of these factors in ace ti282a mutants which carry a putative null allele of the fgf8 gene (Reifers et al., 1998) . Fgf8 function has been implicated in various aspects of embryonic development. Homozygous ace embryos display defects in proper MH organizer maintenance (Reifers et al., 1998) and row 1 organizer function (Shanmugalingam et al., 2000) , in tectum patterning (Picker et al., 1999) and speci®cation of cerebellar fate (Reifers et al., 1998 and unpublished observations) , as well as in forebrain patterning including commissure formation (Shanmugalingam et al., 2000) . Additionally, defects can be found in somitogenesis (Brand et al., 1996) , heart development (Reifers et al., 2000b) , inner ear development (Adamska et al., 2000 ; S. Le Âger and M. Brand, manuscript in preparation) and proper development of neural crest derivatives (H. Grandel, personal communication).
We found that in homozygous ace embryos, both erm and pea3 expression levels are reduced or completely lost in various expression domains. Differences in the expression pattern of these genes became apparent during late gastrulation. At tailbud stage, the presumptive forebrain region and the trunk/tailbud expression are unaffected by the ace mutation ( Fig. 2A) . However, a striking difference between ace embryos and wild-type siblings could be observed at the posterior midbrain/anterior hindbrain level (Fig. 2A±C) . Wild-type expression at this location comprises at least three distinct domains: a wing-like expression domain overlapping partially with the expression domain of pax2.1, a medial domain in the prospective ventral hindbrain and two longitudinal stripes in the adjacent ectoderm that contain the presumptive otic placode in their posterior part (Fig. 2B,C) . Intriguingly, both the wing-shaped domain and the lateral stripes are absent in ace embryos at this stage, while the medial hindbrain domain is strongly reduced (Fig. 2B H ,C H ). During later development, MHB expression is not regained in ace (Fig. 2D,F,I ).
In contrast to the situation in ace mutants, the onset of expression of both erm and pea3 is normal (data not shown) in homozygous noi tu29a embryos which lack the pax2.1 gene function (Lun and Brand, 1998) . However, in no isthmus (noi) mutants, a downregulation of both erm and pea3 can be observed at the MH junction from the 8 somite stage onwards, and this loss persists to later stages of development ( Fig. 2H and data not shown) . Taking into account that fgf8 transcription becomes dependent on functional Pax2.1 at that time point (Lun and Brand, 1998) , this ®nding can be reconciled with the concept that fgf8 is the primary regulator of erm and pea3 in the MH region. While MHB expression of erm and pea3 is lost in ace mutants, these embryos start to re-express both genes in the ectodermal domain adjacent to the MH territory during early somitogenesis. A doublestaining with a probe for pax2.1 reveals that in wild-type embryos (Fig. 2D ) this lateral expression extends anteriorly to the level of the MHB and encloses the lateral pax2.1 expression domain at the hindbrain level that marks the otic placode at this stage (S. Le Âger and M. Brand, unpublished observations). In ace embryos of the same stage ( Fig.  2D H ), the posterior part of this expression domain containing the otic placode is not affected, while the anterior part is missing (arrows in Fig. 2D ,D H ). In addition to expression in the MH region, erm and pea3 transcription is affected in various other tissues in which ace/fgf8 is known to be involved. These include the somites where expression is completely missing (Fig. 2E) . Residual expression can be found in the intermediate mesoderm in an overlap with pax2.1 (red arrowhead in Fig. 2E H ) at the level of the ®rst somites, the presumptive pronephros. In addition, the developing eye, the forebrain, and the olfactory placodes show reduced staining (Fig. 2F ) that could result from the expression of additional Fgfs in this region. At the 18 somite stage, a strong reduction in premigratory neural crest tissue can be observed (Fig. 2F H ). This is in agreement with later defects in the cranial skeleton found in ace mutant ®sh (H. Grandel, unpublished).
Onset and maintenance of erm and pea3 transcription are dependent on Fgf signaling throughout the embryo
Several erm and pea3 expression domains are affected in ace embryos, but others are unchanged compared to wildtype embryos, including expression in the gastrulating embryo, the early forebrain expression, and expression at the hindbrain level, while others are only mildly affected by the ace mutation. In order to test whether other Fgfs are involved in the establishment or maintenance of the persisting expression domains, we chose two ways of experimentally interfering with all Fgf signaling in the embryo. First, we injected embryos with different doses of sprouty4 mRNA and analyzed the expression of erm and pea3 at the gastrula stage. sprouty4 is a zebra®sh homologue of the Drosophila gene sprouty and is a putative intracellular inhibitor of tyrosine kinase signaling (Hacohen et al., 1998; Casci et al., 1999; Fu Èrthauer et al., 2001) . The unilateral injection of high doses (150 pg) of sprouty4 lead to no apparent morphological aberrations at the gastrula stage (not shown). As to the expression of erm and pea3, low doses (75 pg) of misexpressed sprouty4 did not cause a clear phenotype n 40. In contrast, high doses (150 pg) lead to unilateral absence of erm or pea3 in one-third of the embryos (n 3=9 and 3/11, respectively), while the non-injected side appears not to be affected (Fig. 3A,B) . In the remaining cases, only patches of reduced staining or no reduction could be observed. In either case, reduction of erm or pea3 staining was always limited to cells that were derived from the injected blastomere, as indicated by the detection of the injection marker beta-Galactosidase. This argues in favor of a cell-autonomous effect of sprouty4, as would be inferred from its mode of action in Drosophila (Casci et al., 1999) .
As a second approach that would allow us to resolve the temporal aspects of Fgf dependence, we selectively applied a pharmacological inhibitor of Fgf signaling, SU5402, at various stages of development. SU5402 has been shown to block the kinase domain of Fgf receptor 1, thereby preventing its activating function (Mohammadi et al., 1997) . Since this domain is identical in all four Fgf receptors, SU5402 can be used as a general inhibitor of Fgf signaling and phenocopy aspects of the ace mutant phenotype (Reifers et al., 2000b and data not shown). To follow the requirement of Fgf activity for gene expression over a longer period of development, we applied SU5402 in individual experiments during the following intervals: (i) 30±60% epiboly, (ii) 60% epiboly to tailbud, (iii) tailbud to 7 somite stage, (iv) 7±12 somite stage, and (v) 12±18 somite stage. At all experimental stages, we found that after inhibitor treatments, erm and pea3 transcripts were hardly detectable or completely absent from the inhibited embryos, while non-treated siblings displayed wild-type expression (Fig. 3C±F H and data not shown). This ®nding indicates that FGF signaling is necessary for both onset and maintenance of erm and pea3 transcription throughout embryogenesis.
Both Fgf8 and Fgf3 can elicit ectopic erm and pea3 transcription
The Fgf interference experiments suggest that Fgf signaling is necessary for the proper onset and maintenance of erm and pea3 transcription. In order to investigate whether Fgf is also suf®cient to activate transcription of these factors, we performed two types of gain-of-function experiments. First, in order to test the ability of fgf3 to elicit erm or pea3 transcription, we injected 75±150 pg fgf3-RNA in one of the two blastomeres and analyzed gene expression in the gastrula. We ®nd that this injection leads to a global overexpression of both erm and pea3 throughout the embryo on both the injected and the non-injected sites, suggesting that fgf3 is suf®cient to drive the expression of these genes during gastru- lation. As a positive control, we tested for the induction of sprouty4, a potential target of Fgf signaling (Fu Èrthauer et al., 2001 ). All injected embryos displayed global induction of sprouty4 in the same manner as erm or pea3 expression (data not shown). Phenotypically, we noticed that fgf3 injections also caused a weak dorsalization of the embryos (Fig.  4A  H ) , similar to what was described after fgf8 misexpression (Fu Èrthauer et al., 1997; Reifers et al., 1998) .
Because global Fgf overexpression might induce erm and pea3 indirectly, we next tested whether Fgf8 is directly able to elicit pea3 transcription after implantation of Fgf8-coated heparin beads. We implanted beads into shield-stage embryos from heterozygous ace intercrosses and analyzed gene expression in the gastrula. In half of the analyzed cases n 8=17, we ®nd that pea3 is transcriptionally activated as a local response to the beads (see Fig. 4D ,D H ). In the remaining cases, pea3 was induced all over the embryo (not shown), probably re¯ecting a higher protein dosage due to variation in the coating and/or the release of Fgf8. In agreement with this interpretation, all these embryos had an elongated and dorsalized appearance, while the embryos that showed local responses had a normal shape.
We were not able to distinguish ace from wild-type embryos in the globally affected cases. However, at least one of the embryos displaying a local response to the bead implantation could be clearly assigned to be ace homozygous on the basis of its characteristic loss of endogenous expression domains in the non-implanted side (Fig. 4E) . This case is indicative of the fact that endogenous fgf8 gene function is not needed to mediate the local response observed in the bead implantation experiments. In summary, we conclude that Fgf8 and Fgf3 can elicit pea3 transcription outside its endogenous domains, and that presence of Fgf signals is the main factor causing its expression.
Fgf8 and Fgf3 may act to co-regulate early forebrain expression of pea3
From the inhibition results we concluded that an Fgf signal is responsible for the proper onset and maintenance of the putative forebrain expression domain of erm and pea3. The analysis of the ace mutant and the co-expression analysis showed that the Fgf8 gene is not the primary regulator of these domains in the pregastrula. Therefore, we investigated the role of fgf3 which is expressed at the right place and time and has previously been suggested to contribute to forebrain patterning (Shanmugalingam et al., 2000) . We aimed at analyzing the expression of the ETS factors after depleting the embryo of Fgf3. Since no fgf3 mutant has been reported in zebra®sh to date, we chose a recently developed gene`knock-down' strategy (Nasevicius and Ekker, 2000) , by injecting morpholino-antisense-oligonucleotides directed against the translational start site of fgf3 (fgf3-MO) or fgf8 (fgf8-MO) into the yolk cell of two to four cell stage embryos and ®xing them at tailbud stage for whole-mount ISH with the pea3 probe. To assess the ef®-ciency of the procedure, we let part of the embryos develop to 28 h post fertilization (hpf) and analyzed their overall morphology.
Injection of fgf8-MO results in a morphological phenotype that is strikingly similar to the phenotype displayed by ace homozygous mutants (Araki and Brand, 2001 ). In our experiments, 100% n 33=33 of the 28 hpf larvae displayed a lack of the isthmus and cerebellum and a reduced ear vesicle, both indicative of the genetic ace mutant phenotype, while injection of a standard control morpholino never resulted in such a phenotype (Fig. 5B,D , and data not shown). In further agreement with the genetic ace mutation, we observe a similar reduction of the pea3 expression domain at the MH level: staining in the expression domains overlapping with the pax2.1 domain as well as the ectodermal lateral domain including the otic vesicle were absent, while the hindbrain expression was diminished to a medial region. The forebrain expression in these embryos appeared to be normal or slightly reduced (not shown).
When we additionally added fgf3-MO to the injection solutions, 12.5% n 3=24 of the fgf3-MO/fgf8-MOdouble-injected embryos displayed a complete loss of pea3 forebrain expression (Fig. 5E) ; 87.5% n 21=24 displayed a reduced forebrain expression compared to control embryos. This indicates a potential contribution of Fgf3 expression to the anteriormost expression domain of pea3. To determine whether the observed effect on the forebrain expression of pea3 was speci®c to the inhibition of fgf3 translation, we looked for morphological defects at 28 hpf that could be due to a loss of Fgf3 protein. Although a zebra®sh mutant for fgf3 has not been reported yet, genetic studies in mice (reviewed in Torres and Giraldez, 1998) and zebra®sh (S. Le Âger and M. Brand, unpublished observations) make it likely that fgf3 synergizes with fgf8 and contributes to inner ear development. Using the ear vesicle as a readout for the ef®ciency of our interference with fgf3 translation, we observed that fgf8-MO/fgf3-MO injected embryos have smaller ear vesicles than displayed in the ace mutants (compare Fig. 5F ,D) with a high consistency n 25=26. From these experiments, we conclude that Fgf3 and Fgf8 co-operate in regulating erm and pea3 expression in the forebrain.
Discussion
We demonstrate that transcription of the ETS factors erm and pea3 is tightly linked with active Fgf signaling during gastrulation and somitogenesis stages of zebra®sh embryos: (1) erm and pea3 are expressed in close proximity to centers of Fgf signaling throughout embryogenesis; (2) erm and pea3 transcript levels are selectively reduced in various regions of Fgf8 activity in acerebellar (ace)/fgf8 mutants; (3) general interference with Fgf signaling by overexpression of sprouty4 or application of the FgfR inhibitor SU5402 leads to the complete absence of erm and pea3 transcripts in the affected tissues, an effect that can be observed throughout embryogenesis with fast kinetics; (4) Fgf3 and Fgf8 ectopically elicit erm and pea3 transcription in overexpression or bead implantation experiments; and (5) pea3 can be selectively reduced in the early forebrain anlage by co-inhibition of fgf8 and fgf3 translation through antisense-morpholino oligomers. These ®ndings lead us to conclude that erm and pea3 transcription is tightly linked to Fgf signaling and may provide a direct intracellular readout for active Fgf signaling. 
erm and pea3 are transcriptionally regulated by both Fgf8 and Fgf3 signaling
Redundancy is a general problem encountered in Fgf signaling. The identi®cation of target genes of Fgf signaling therefore may serve two needs: they facilitate the analysis of signaling events, and they may be important to understand how different Fgf signals are integrated on the cellular level. Several lines of evidence lead us to conclude that at least two Fgf signals ± Fgf8 and Fgf3 ± are involved in regulating the transcription of erm and pea3. The ®rst line of evidence is the apparent co-expression of erm and pea3 expression with expression sites of fgf8 and fgf3, including the blastoderm margin of the pregastrula embryo, the germ ring and shield, the axial mesoderm of the gastrulating embryo as well as the early expression domain of fgf3 in the presumptive forebrain and the wing-shaped expression of fgf8 in the future midbrain±anterior hindbrain region. Later stages show correlations in various expression domains, including the somites, the eye anlage, the ear placode, and the MHB.
Secondly, Fgfs are believed to exert their function over some distance by a diffusion mechanism that would also allow the creation of concentration gradients. In agreement with this, both our analysis of wildtype expression and our observations made upon misexpression of fgf3 RNA or implantation of Fgf8-coated beads demonstrate that erm and pea3 transcription is upregulated in the tissue surrounding local Fgf sources, in patterns that are conceivably more diffuse. Furthermore, there is a characteristic spatial and temporal correlation between the dynamics of fgf expression and the detectable mRNAs of Erm and Pea3, as would be expected if the two genes are inducible targets of Fgf signaling. Notably, erm expression generally appears to be less con®ned in its domains compared to pea3 distribution. This could re¯ect a different sensitivity to Fgf signals, but might also be due to secondary mechanisms re®ning pea3 expression to a smaller subdomain of cells. Either mechanism could have important consequences for the organization of downstream events.
Thirdly, the conclusions from the expression analysis and the gain-of-function experiments are further supported by the selective interference with Fgf8 or Fgf3 protein levels, either by studying homozygous ace/fgf8 mutant embryos or by selective knock-down of protein translation through morpholino-antisense oligomers. For ace/fgf8 mutant or fgf8-MO injected embryos, the most striking phenotype in the change of expression pattern concerns the MH region. At tailbud stage, ace mutants lack most of erm and pea3 expression in this territory, including the domain that overlaps with pax2.1 expression at the presumptive MHB and most of the hindbrain expression, while a small hindbrain domain is persisting. MHB expression is never regained in ace, in agreement with the fact that ace embryos also fail to induce and maintain MHB expression of other fgf genes like fgf17 that might be able to rescue target gene expression (Reifers et al., 2000a) . Conversely, erm and pea3 expression at the MHB level is retained at wild-type levels in noi/ pax2.1 mutant embryos up to early somitogenesis stages, but is progressively lost thereafter. This loss correlates with the progressive loss of fgf8 expression from this region in noi mutants und therefore stresses the major role of Fgf8 for Fgf signaling in this territory.
At the gastrula stage, erm and pea3 expression in the presumptive forebrain does not seem to be strongly affected in ace mutants. Our morpholino-antisense oligomer injections suggest that fgf3 is a potential co-regulator of fgf8 for expression of pea3 in this domain. This is consistent with our ®nding that fgf3 can activate pea3 upon misexpression, and gets additional support from our co-expression analysis. In addition, this evidence is complementary to our previous ®nding that additional Fgf signaling acts redundantly with Fgf8 in early forebrain development (Shanmugalingam et al., 2000) , and suggests that Fgf3 is one of the Fgfs involved.
Other sites in which erm and pea3 expressions are affected in ace mutant embryos include the somites, the developing eye, and the forebrain. These ®ndings are in good agreement with aspects of the mutant analysis and therefore will not be discussed in detail here. Interestingly, the loss of expression in the hindbrain-derived neural crest correlates with a loss of craniofacial skeleton phenotype displayed by ace mutants that is indicative of a role of fgf8 in normal development of this tissue (H. Grandel, unpublished).
erm and pea3 transcription can be ectopically activated by Fgf8 orFgf3
One interesting question resulting from the ®nding that Fgf8 and Fgf3 are involved in regulating erm and pea3 transcription is whether they are also suf®cient to induce these factors ectopically. Indeed, both ectopically provided fgf3 mRNA or implanted Fgf8 beads were able to elicit ectopic expression of erm and pea3 in regions where it is not naturally expressed. In the case of fgf3 overexpression in one half of the embryo, massive upregulation of erm and pea3 transcripts could be detected both on the injected and the contralateral sides. In addition, ectopically provided Fgf8 on heparin-coated beads elicited a local response surrounding the bead. Since this local response could also be observed in homozygous ace embryos, endogenous Fgf8 is not required to mediate this inductive effect. While the qualitative result ± the ectopic upregulation of target mRNA ± is the same in both experiments, the apparent differences in the size of the affected area most likely result from the differences in the experimental conditions: RNA injection at the two-cell stage presumably results in Fgf3 expression prior to the shield stage, the time point at which the implantations were performed. In addition, the amount of protein secreted by the RNA-injected cells might differ from the protein amount coated on the beads. Notably, the bead implantation experiments also demonstrate that pea3 can be detected within at most 4 h after application of Fgf8.
Potentially, this time span is even shorter, but has not yet been challenged experimentally.
General dependence of erm and pea3 transcription on Fgf signaling
In addition to the transcriptional activation of erm and pea3 upon creation of ectopic Fgf8 or Fgf3 signaling domains, we ®nd evidence that general interference with Fgf signaling correlates with an overall loss of transcripts of these genes. After sprouty4 misexpression, we observed a complete loss of erm or pea3 staining in 30% of the embryos injected with 150 pg sprouty4 mRNA. The loss of transcripts was always con®ned to the progeny of the injected blastomere, as demonstrated by detection of the injection marker lacZ. The seemingly low penetrance of this phenotype is in agreement with the observation that sprouty4 overexpression causes only transient effects in zebra®sh (Fu Èrthauer et al., 2001) . In accordance with the mode of action that has been proposed for Drosophila photoreceptor differentiation (Casci et al., 1999) , sprouty4 thus seems to act as a cell-autonomous inhibitor of Fgf signaling.
While the sprouty4 misexpression experiment does not distinguish between a loss of transcript and a failure to activate transcription, the selective application of the Fgf receptor inhibitor SU5402 at various time points during embryonic development provided evidence that interference with Fgf receptor activation reduces erm and pea3 transcripts to a minimum level within 2.5 h or even faster after application. This loss of transcripts is observed even in later segmentation stages, suggesting that erm and pea3 transcription remains tightly linked to Fgf signaling during embryonic development.
The ®nding that all expression domains of erm and pea3 are susceptible to interference with Fgf signaling suggests that other Fgfs besides Fgf8 and Fgf3 are able to control transcription of these factors. In return, expression domains that are remaining in speci®c loss-of-function situations are thus likely re¯ecting redundant expression of other fgf genes. Thus, ace embryos display only a transient lack in their presumptive otic expression domain around tailbud stage, which presumably re¯ects Fgf activity at the hindbrain level in early somitogenesis. Moreover, ace embryos do not display defects in erm or pea3 expression prior to the late gastrula stage, which is unlikely to be due to a rescue effect of maternal fgf8 mRNA, since fgf8-MO injections ± which should also inhibit translation of maternal mRNAs ± do not create a different phenotype. Instead, fgf3 and at least one other member of the fgf gene family are expressed in the germring and may mask the effects of early loss of fgf8 function (I. Araki and M. Brand, unpublished) .
Perspectives
Our results suggest that erm and pea3 are two direct target genes activated by cells that are receiving an Fgf8 or Fgf3 signal as well as other, so far uncharacterized Fgf signals. Thus, these genes are good candidates for factors that will relay further cellular responses to Fgf signaling and serve to integrate Fgf signaling with other signals. Indeed, both factors are very likely nuclear targets of Fgf signaling also on the protein level, as suggested by in vitro studies O'Hagan et al., 1996 ; see also Wasylyk et al., 1998) .
Further studies will thus focus more on the protein function of Erm and Pea3, taking into account the likely activation of these factors by various other signaling cascades (O'Hagan et al., 1996; O'Hagan and Hassell, 1998; Janknecht et al., 1996) and the possibility of molecular interactions with other transcription factors, including paired-and POU homeodomain proteins that can interact with ETS domain proteins (Bradford et al., 2000; Fitzsimmons et al., 1996) . Molecules of both classes are known to be essential for MHB development or function (Favor et al., 1996; Urbanek et al., 1997; Lun and Brand, 1998; Burgess et al., 2001) , and Erm and Pea3 are attractive candidates for relaying Fgf signaling into the transcriptional regulation involved in MHB patterning.
Since single loss-of-function studies in mice de®cient for either Pea3 or the Pea3 class ETS domain factor ER81 have not been reported to yield early developmental defects (Arber et al., 2000; Laing et al., 2000) , it is likely that multiple loss-of-function studies are necessary to address the functional relevance of the Pea3 family of ETS domain factors in more depth.
Experimental procedures
Fish strains and maintenance
Zebra®sh embryos were obtained from natural spawning and maintained under standard conditions (Wester®eld, 1994) . For all injection and transplantation experiments, ®sh were kept in Ringer's solution. Embryos were staged as described by Kimmel et al. (1995) or in hpf at 288C. Heterozygous carriers of the ace ti282a mutation (Reifers et al., 1998) or the noi tu29a mutation (Lun and Brand, 1998) were identi®ed by random intercrosses. Homozygous mutant embryos were obtained by heterozygote mating.
Live morphology
Embryos were anesthetized with 3-aminobenzoic acid ethyl ester (MESAB) and embedded in methylcellulose for photography.
Analysis of gene expression
Standard methods for whole-mount RNA ISH were used as described by Reifers et al. (1998) . The following probes have been used: pax2.1 (Krauss et al., 1991; Pu Èschel et al., 1992) , fgf8 (Fu Èrthauer et al., 1997; Reifers et al., 1998 ), spry4 (Fu Èrthauer et al., 2001 , fgf3 (Kiefer et al., 1996) , pea3, and erm .
RNA injections
cDNAs of fgf3, sprouty4, and lacZ were subcloned into pCS2 1 (Rupp et al., 1994) , and linearized plasmid DNA was used for in vitro transcription (SP6 mMESSAGE mMACHINE kit (Ambion/AMS Biotechnology GmbH, Wiesbaden, Germany)). Injection solutions contained ®nal concentrations of 0.2 M KCl and 0.2% phenol red. The amount of RNA injected was estimated based on the concentration of the solution and the calculated volume of a sphere of RNA solution injected into oil at the same pressure settings. RNA solution was backloaded into borosilicate capillaries prepared on a Sutter puller and injected into single blastomeres of two-cell stage embryos. The progeny of the injected blastomere was visualized by detection with a beta-Galactosidase speci®c antibody (Promega GmbH, Mannheim, Germany, 1:500) after ISH (Dornseifer et al., 1997) .
Bead implantations
Bead implantations are described in Reifers et al. (2000b) . Beads coated with Fgf8b (R&D Systems GmbH, Wiesbaden, Germany) were implanted at indicated regions of wild-type and ace mutant embryos between shield stage and 70% of epiboly. Embryos were ®xed at tailbud stage and processed for ISH.
Inhibitor treatment
For inhibition of the Fgf pathway, wild-type embryos were treated with the chemical inhibitor SU5402, interfering with the ATPase domain of Fgf receptors (CalbiochemNovabiochem GmbH, Schwalbach, Germany; Mohammadi et al., 1997) . The inhibitor was dissolved to 8 mM in DMSO, aliquots were kept frozen at 2208C and applied at a ®nal concentration of 16 mM in embryo medium at 288C in the dark. After treatments, embryos were directly ®xed for ISH.
Morpholino`knock-down' experiments
To speci®cally block translation of mRNAs, morpholinoantisense oligomers (Nasevicius and Ekker, 2000) directed against the translational start sites of fgf8 and fgf3 were used (obtained from GeneTools, LLC, Corvallis, OR). The sequence of the oligos used was 5
H -GAGTCTCATGTTTA-TAGCCTCAGTA-3 H (fgf8-MO) and 5 H -CAGTAACAA-CAAGAGCAGAATTATA-3 H (fgf3-MO). Morpholinos were resuspended in water and stored as 5 mM stock solutions at 2208C. Working solutions were prepared in 0.2 M KCl and 0.2% phenol red. The injected amounts were estimated as described for RNA injections. Injected amounts of either fgf8-MO or fgf3-MO were 2.5 ng/embryo.
